Ngā hua rapu - Allison Brashear
- E whakaatu ana i te 1 - 17 hua o te 17
-
1
-
2
Genotype-structure-phenotype relationships diverge in paralogs <i>ATP1A1</i> , <i>ATP1A2</i> , and <i>ATP1A3</i> mā Kathleen J. Sweadner, Elena Arystarkhova, John T. Penniston, Kathryn J. Swoboda, Allison Brashear, Laurie J. Ozelius
I whakaputaina 2019Revisão -
3
A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystonia mā Virgilio Gerald H. Evidente, Hubert H. Fernandez, Mark S. LeDoux, Allison Brashear, Susanne Grafe, Angelika Hanschmann, Cynthia Comella
I whakaputaina 2013Artigo -
4
Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke mā Allison Brashear, Mark Forrest Gordon, Elie P. Elovic, V. Daniel Kassicieh, Christina Marciniak, Mai Do, Chia-Ho Lee, Stephen Jenkins, Catherine C. Turkel
I whakaputaina 2002Artigo -
5
Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study mā Joseph Jankovic, Daniel Truong, Atul T. Patel, Allison Brashear, Marian L. Evatt, Roman G. Rubio, Chad K. Oh, Daniel Snyder, Gill Shears, Cynthia Comella
I whakaputaina 2018Artigo -
6
Revising rapid‐onset dystonia–parkinsonism: Broadening indications for <i>ATP1A3</i> testing mā Ihtsham Haq, Beverly M. Snively, Kathleen J. Sweadner, Cynthia K. Suerken, Jared Cook, Laurie J. Ozelius, Charlotte Miller, W. Vaughn McCall, Christopher T. Whitlow, Allison Brashear
I whakaputaina 2019Artigo -
7
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED] mā David M. Simpson, Andrew Blitzer, Allison Brashear, Cynthia Comella, Richard Dubinsky, Mark Hallett, Joseph Jankovic, Barbara Karp, Christy L. Ludlow, Janis M. Miyasaki, M. Naumann, Y. So
I whakaputaina 2008Revisão -
8
<i>ATP1A3</i>mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia mā Allison Brashear, Jonathan W. Mink, Deborah F. Hill, Niki Boggs, W. Vaughn McCall, Mark Stacy, Beverly M. Snively, Laney S. Light, Kathleen J. Sweadner, Laurie J. Ozelius, Leslie Morrison
I whakaputaina 2012Revisão -
9
Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition mā Elena Arystarkhova, Ihtsham Haq, Timothy Luebbert, Fanny Mochel, Rachel Saunders‐Pullman, Susan Bressman, Polina Feschenko, Cynthia Salazar, Jared Cook, Scott Demarest, Allison Brashear, Laurie J. Ozelius, Kathleen J. Sweadner
I whakaputaina 2019Artigo -
10
Psychiatric disorders in rapid-onset dystonia-parkinsonism mā Allison Brashear, Jared Cook, Deborah F. Hill, Alethea Amponsah, Beverly M. Snively, Laney S. Light, Niki Boggs, Cynthia K. Suerken, Mark Stacy, Laurie J. Ozelius, Kathleen J. Sweadner, W. Vaughn McCall
I whakaputaina 2012Artigo -
11
Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings mā Adrian L. Oblak, Matthew C. Hagen, Kathleen J. Sweadner, Ihtsham Haq, Christopher T. Whitlow, Joseph A. Maldjian, Francine Epperson, Jared Cook, Mark Stacy, Jill R. Murrell, Laurie J. Ozelius, Allison Brashear, Bernardino Ghetti
I whakaputaina 2014Artigo -
12
Mutations in the Na+/K+-ATPase α3 Gene ATP1A3 Are Associated with Rapid-Onset Dystonia Parkinsonism mā Patrícia de Carvalho Aguiar, Kathleen J. Sweadner, John T. Penniston, Jacek Zaremba, Liu Liu, Marsha Caton, Gurutz Linazasoro, Michel Borg, Marina A.J. Tijssen, Susan Bressman, William B. Dobyns, Allison Brashear, Laurie J. Ozelius
I whakaputaina 2004Artigo -
13
Distinct neurological disorders with ATP1A3 mutations mā Erin L. Heinzen, Alexis Arzimanoglou, Allison Brashear, Steven J. Clapcote, Fiorella Gurrieri, David B. Goldstein, Sigurður H Jóhannesson, Mohamad A. Mikati, Brian Neville, Sophie Nicole, Laurie J. Ozelius, Hanne Poulsen, Tsveta Schyns, Kathleen J. Sweadner, Arn van den Maagdenberg, Bente Vilsen
I whakaputaina 2014Revisão -
14
Novel mutations in <i>ATP1A3</i> associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly mā Alex R. Paciorkowski, Sharon S. McDaniel, Laura A. Jansen, Hannah M. Tully, Emily Tuttle, Dalia Ghoneim, Srinivasan Tupal, Sonya A. Gunter, Valeria Vasta, Qing Zhang, Thao Tran, Yi B. Liu, Laurie J. Ozelius, Allison Brashear, Kathleen J. Sweadner, William B. Dobyns, Sihoun Hahn
I whakaputaina 2015Artigo -
15
Research conference summary from the 2014 International Task Force on <i>ATP1A3</i> -Related Disorders mā Hendrik Rosewich, Matthew Sweney, Suzanne D. DeBrosse, Kevin C. Ess, Laurie J. Ozelius, Eva Andermann, Frédérick Andermann, Gene Andrasco, Alice Belgrade, Allison Brashear, Sharon Ciccodicola, Lynn Egan, Alfred L. George, Aga Lewelt, Joshua Magelby, Mario Merida, Tara Newcomb, Vicky Platt, D. Poncelin, Sandra P. Reyna, Masayuki Sasaki, Márcio Sotero de Menezes, Kathleen J. Sweadner, Louis Viollet, Mary L. Zupanc, Kenneth Silver, Kathryn J. Swoboda
I whakaputaina 2017Artigo -
16
Efficacy and safety of abobotulinumtoxinA in spastic lower limb mā Jean‐Michel Graciès, Alberto Esquenazi, Allison Brashear, Marta Banach, Serdar Koçer, Robert Jech, Svetlana Khatkova, Ján Benetin, Michele Vecchio, Peter McAllister, Jan Ilkowski, Stanisław Ochudlo, F. Catus, Anne Sophie Grandoulier, Claire Vilain, Philippe Picaut, Steven Faux, John Olver, Senén González, Ian Baguley, Katya Kotschet, John Estell, Thierry Deltombe, Thierry Lejeune, Robert Jech, Jean‐Michel Graciès, Alfons Schnitzler, Pierre Decavel, Philippe Marque, F. Boyer, Marie-Ève Isner-Horobeti, Claude Desnuelles, Zoltán Dénes, Attila Csányi, Gábor Fazekas, Katalin Guba, Michele Vecchio, Ugo Dimanico, Giacomo P. Comi, Marta Banach, Monika Rudzińska, Anna Kaminśka, Jan Ilkowski, Stanisław Ochudlo, Małgorzata Krawczyk, Jorge Jacinto, Fernando Parada, Svetlana Khatkova, A A Skoromets, Sofia Timerbaeva, Ján Benetin, Peter Valkovič, Serdar Koçer, Allison Brashear, Alberto Esquenazi, Steven R. Edgley, David M. Simpson, Michael W. O’Dell, Gerard E. Francisco, Erika Driver Dunckley, Peter McAllister, Jeffrey B. Gross, Peter Hedera, Heather W. Walker, Fatma Gül, Bruce Rubin, Ziyad Ayyoub, Stuart Isaacson, Michael Wimmer, James P. Sutton
I whakaputaina 2017Artigo -
17
Dystonia and Tremor mā Aasef G. Shaikh, Sinem Balta Beylergil, Laura Scorr, Gamze Kilic‐Berkmen, Alan Freeman, Christine Klein, Johanna Junker, Sebastian Loens, Norbert Brüggemann, Alexander Münchau, Tobias Bäumer, Marie Vidailhet, Emmanuel Roze, Cécilia Bonnet, Joseph Jankovic, Joohi Jimenez‐Shahed, Neepa Patel, Laura Marsh, Cynthia Comella, Richard L. Barbano, Brian D. Berman, Irene A. Malaty, Aparna Wagle Shukla, Stephen G. Reich, Mark S. LeDoux, Alfredo Berardelli, Gina Ferrazzano, Natividad Stover, William G. Ondo, Sarah Pirio Richardson, Rachel Saunders‐Pullman, Zoltán Mari, Pinky Agarwal, Charles H. Adler, Sylvain Chouinard, Susan H. Fox, Allison Brashear, Daniel Truong, Oksana Suchowersky, Samuel Frank, Stewart A. Factor, Joel S. Perlmutter, Hyder A. Jinnah
I whakaputaina 2020Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Dystonia
Internal medicine
Disease
Parkinsonism
Psychiatry
Biology
Genetics
Psychology
Gene
Pediatrics
Physical medicine and rehabilitation
Anesthesia
Botulinum toxin
Mutation
Neuroscience
Surgery
Cervical dystonia
Endocrinology
Pathology
Phenotype
Physical therapy
Alternative medicine
Atrophy
Biochemistry
Botulinum neurotoxin
Chemistry
Dysphagia
Microcephaly
Missense mutation